Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Granulomatosis with Polyangiitis | 6 | 2011 | 39 | 1.310 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 8 | 2011 | 37 | 1.130 |
Why?
|
| Myeloblastin | 6 | 2011 | 19 | 0.760 |
Why?
|
| Intensive Care Units | 6 | 2010 | 539 | 0.650 |
Why?
|
| Hydrochlorothiazide | 2 | 2005 | 60 | 0.420 |
Why?
|
| Motorcycles | 1 | 2012 | 7 | 0.380 |
Why?
|
| Deer | 1 | 2012 | 15 | 0.370 |
Why?
|
| Accidents, Traffic | 1 | 2012 | 111 | 0.350 |
Why?
|
| Antihypertensive Agents | 2 | 2005 | 410 | 0.340 |
Why?
|
| Abortion, Septic | 2 | 2004 | 3 | 0.330 |
Why?
|
| Deep Sedation | 1 | 2010 | 7 | 0.330 |
Why?
|
| Critical Illness | 3 | 2010 | 628 | 0.310 |
Why?
|
| Conscious Sedation | 1 | 2010 | 62 | 0.310 |
Why?
|
| International Classification of Diseases | 1 | 2010 | 101 | 0.310 |
Why?
|
| Death | 1 | 2009 | 80 | 0.290 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 394 | 0.280 |
Why?
|
| Etomidate | 1 | 2006 | 6 | 0.250 |
Why?
|
| Tissue and Organ Procurement | 1 | 2009 | 248 | 0.240 |
Why?
|
| Adrenal Insufficiency | 1 | 2006 | 33 | 0.240 |
Why?
|
| Hypertension | 2 | 2005 | 1402 | 0.230 |
Why?
|
| Heart Arrest | 1 | 2009 | 376 | 0.220 |
Why?
|
| Shock, Septic | 1 | 2006 | 157 | 0.220 |
Why?
|
| Critical Care | 1 | 2010 | 698 | 0.210 |
Why?
|
| Hospital Mortality | 3 | 2004 | 1095 | 0.200 |
Why?
|
| Patient Admission | 1 | 2004 | 190 | 0.200 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2002 | 34 | 0.200 |
Why?
|
| Point-of-Care Systems | 1 | 2005 | 194 | 0.190 |
Why?
|
| Seasons | 1 | 2004 | 327 | 0.190 |
Why?
|
| Blood Glucose | 1 | 2005 | 1184 | 0.170 |
Why?
|
| Length of Stay | 2 | 2004 | 1392 | 0.150 |
Why?
|
| Heart Valve Diseases | 2 | 1999 | 181 | 0.140 |
Why?
|
| Adult | 11 | 2012 | 31617 | 0.140 |
Why?
|
| APACHE | 4 | 2004 | 57 | 0.140 |
Why?
|
| Age Distribution | 2 | 2012 | 426 | 0.140 |
Why?
|
| Middle Aged | 10 | 2010 | 28912 | 0.130 |
Why?
|
| Female | 16 | 2012 | 71395 | 0.130 |
Why?
|
| Histiocytosis, Non-Langerhans-Cell | 1 | 1996 | 16 | 0.130 |
Why?
|
| Strongyloidiasis | 1 | 1996 | 16 | 0.130 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1996 | 9 | 0.120 |
Why?
|
| Male | 15 | 2012 | 65480 | 0.120 |
Why?
|
| Humans | 26 | 2012 | 133192 | 0.120 |
Why?
|
| Endocarditis, Bacterial | 1 | 1996 | 137 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2012 | 17526 | 0.090 |
Why?
|
| North Dakota | 1 | 2012 | 6 | 0.090 |
Why?
|
| Head Protective Devices | 1 | 2012 | 23 | 0.090 |
Why?
|
| Survival Rate | 2 | 2010 | 2204 | 0.090 |
Why?
|
| Glycosylation | 2 | 2009 | 129 | 0.090 |
Why?
|
| Leukocyte Elastase | 2 | 2008 | 22 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2007 | 834 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2012 | 320 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 1996 | 573 | 0.090 |
Why?
|
| Platelet Activation | 1 | 2011 | 71 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 3087 | 0.090 |
Why?
|
| Rural Population | 1 | 2012 | 280 | 0.080 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2009 | 57 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2006 | 3043 | 0.070 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 165 | 0.070 |
Why?
|
| Narcotics | 1 | 2009 | 64 | 0.070 |
Why?
|
| Granuloma, Lethal Midline | 1 | 2008 | 1 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2009 | 111 | 0.070 |
Why?
|
| Aged | 6 | 2010 | 21448 | 0.070 |
Why?
|
| Minnesota | 2 | 2004 | 181 | 0.070 |
Why?
|
| Asparagine | 1 | 2006 | 22 | 0.070 |
Why?
|
| Remission Induction | 1 | 2007 | 307 | 0.070 |
Why?
|
| Serum | 1 | 2006 | 46 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2007 | 6571 | 0.060 |
Why?
|
| Hypertension, Portal | 2 | 1998 | 80 | 0.060 |
Why?
|
| Plasma | 1 | 2006 | 105 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 204 | 0.060 |
Why?
|
| Physicians' Offices | 1 | 2005 | 10 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 2139 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2008 | 464 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2011 | 5435 | 0.060 |
Why?
|
| Hydrocortisone | 1 | 2006 | 246 | 0.060 |
Why?
|
| Cytokines | 1 | 2011 | 1377 | 0.060 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2005 | 53 | 0.060 |
Why?
|
| Medical Futility | 1 | 2004 | 39 | 0.060 |
Why?
|
| Serine Endopeptidases | 1 | 2005 | 199 | 0.060 |
Why?
|
| Argentina | 1 | 2004 | 54 | 0.050 |
Why?
|
| Biomarkers | 3 | 2011 | 3411 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2005 | 218 | 0.050 |
Why?
|
| Recurrence | 1 | 2007 | 1469 | 0.050 |
Why?
|
| Medical Staff, Hospital | 1 | 2004 | 97 | 0.050 |
Why?
|
| Neutrophils | 1 | 2005 | 362 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1556 | 0.050 |
Why?
|
| Health Services Research | 1 | 2004 | 188 | 0.050 |
Why?
|
| Logistic Models | 2 | 2004 | 1862 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2004 | 335 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 446 | 0.050 |
Why?
|
| Diuretics | 1 | 2002 | 168 | 0.050 |
Why?
|
| Cause of Death | 1 | 2004 | 504 | 0.050 |
Why?
|
| Disease Progression | 1 | 2007 | 2242 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2004 | 423 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2010 | 3715 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2004 | 13094 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2005 | 1411 | 0.040 |
Why?
|
| Antiphospholipid Syndrome | 1 | 1999 | 27 | 0.040 |
Why?
|
| Tricuspid Valve | 1 | 1999 | 62 | 0.040 |
Why?
|
| Chordae Tendineae | 1 | 1998 | 8 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 2286 | 0.040 |
Why?
|
| Incidence | 1 | 2006 | 3385 | 0.040 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 1998 | 19 | 0.030 |
Why?
|
| Prognosis | 2 | 2004 | 5032 | 0.030 |
Why?
|
| Thoracic Injuries | 1 | 1998 | 93 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2010 | 3169 | 0.030 |
Why?
|
| Pregnancy | 2 | 2004 | 7592 | 0.030 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1998 | 76 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2006 | 7137 | 0.030 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1996 | 40 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1998 | 224 | 0.030 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1998 | 182 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1998 | 239 | 0.030 |
Why?
|
| Pregnancy in Adolescence | 1 | 1994 | 52 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 1996 | 395 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1996 | 215 | 0.030 |
Why?
|
| Risk Factors | 2 | 2004 | 10936 | 0.020 |
Why?
|
| Animals | 2 | 2012 | 36191 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2011 | 65 | 0.020 |
Why?
|
| P-Selectin | 1 | 2011 | 74 | 0.020 |
Why?
|
| Cell Line | 2 | 2006 | 2855 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 121 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2011 | 214 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 445 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 470 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2006 | 60 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 103 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2006 | 121 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 48 | 0.020 |
Why?
|
| Mast Cells | 1 | 2006 | 71 | 0.020 |
Why?
|
| Peroxidase | 1 | 2005 | 65 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 389 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2004 | 328 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 1095 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 805 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2785 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1608 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 1049 | 0.010 |
Why?
|
| Rupture | 1 | 1998 | 34 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 1998 | 173 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 1998 | 258 | 0.010 |
Why?
|
| Adolescent | 1 | 1994 | 20550 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1999 | 190 | 0.010 |
Why?
|
| Acute Disease | 1 | 1998 | 1182 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 6541 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 1999 | 474 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1998 | 997 | 0.010 |
Why?
|
| Mice | 1 | 2005 | 18930 | 0.000 |
Why?
|